Lexaria gets ethics board okay for oral GLP-1 study

on MSN ago, source:

Lexaria Bioscience (NASDAQ:LEXX) said a third-party ethics review board has approved a human pilot study evaluating GLP-1 ...

Lexaria Bioscience Corp (LEXX) Stock: A SWOT Analysis

11d ago, source: newsheater

In a nutshell, Lexaria Bioscience Corp (LEXX) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the ...

Lexaria Bioscience ethics review board approval to begin new GLP-1 study

8d ago, source: Pharmabiz

Lexaria Bioscience ethics review board approval to begin new GLP-1 study: Kelowna, BC Thursday, April 18, 2024, 18:00 Hrs [IST] Lexaria Bioscience Corp., a global innovator in dru ...

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks GLP-1 Study Milestone With Ethics Review Board Approval

3d ago, source:

Lexaria, a global innovator in drug delivery platforms, has received approval for its GLP-1 human pilot study #2 by an independent third ...

Lexaria Bioscience Corp. (NASDAQ: LEXX) Bolsters C-Suite With New CFO Appointment

14d ago, source:

Lexaria, a global innovator in drug delivery platforms, has announced the appointment of Nelson Cabatuan, CPA, as its new CFO <li /> Ne ...

Lexaria Bioscience (NASDAQ: LEXX) Focusing on GLP-1 Applications of DehydraTECH(TM)

25d ago, source:

Detailed price information for Lexaria Bioscience Corp WT (LEXXW-Q) from The Globe and Mail including charting and trades.

LEXX Stock Earnings: Lexaria Bioscience Beats EPS for Q2 2024

on MSN ago, source:

LEXX stock results show that Lexaria Bioscience beat analyst estimates for earnings per share the second quarter of 2024.More ...

Economic developers brand Lansing as key leg of Michigan’s ‘Research Triangle’

9d ago, source: crainsgrandrapids

A consortium of groups has set out to brand Lansing as a bioscience destination in a move to better position the region ...

Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study

10d ago, source:

Approved KELOWNA, BC / ACCESSWIRE / April 16, 2024 / (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global ...

Lexaria Bioscience (NASDAQ: LEXX) Bolsters C-Suite with New CFO Appointment

19y ago, source: The Globe and Mail

Lexaria, a global innovator in drug delivery platforms ... Lexaria’s confidence in its recently confirmed focus on important GLP-1 studies Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug ...

Lexaria Bioscience Corp.: Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study

10d ago, source:

Approved KELOWNA, BC / ACCESSWIRE / April 16, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery ...